Use of Panitumumab-IRDye800 to Image Cutaneous Head and Neck Cancer in Mice

Similar Items

• Use of Panitumumab-IRDye800 to Image Microscopic Head and Neck Cancer in an Orthotopic Surgical Model
  od: Heath, C. Hope, i dr.
  Izdano: (2012)
• Preclinical Comparison of Near-Infrared-Labeled Cetuximab and Panitumumab for Optical Imaging of Head and Neck Squamous Cell Carcinoma
  od: Day, Kristine E., i dr.
  Izdano: (2013)
• Safety of panitumumab-IRDye800CW and cetuximab-IRDye800CW for fluorescence-guided surgical navigation in head and neck cancers
  od: Gao, Rebecca W., i dr.
  Izdano: (2018)
• Optimal Dosing Strategy for Fluorescence-Guided Surgery with Panitumumab-IRDye800CW in Head and Neck Cancer
  od: Nishio, Naoki, i dr.
  Izdano: (2020)
• Identification of the optimal therapeutic antibody for fluorescent imaging of cutaneous squamous cell carcinoma
  od: Day, Kristine E., i dr.
  Izdano: (2013)